(1)
GunturuK.; Abu-KhalafM.; SaifM. Hepatic Failure and Hepatorenal Syndrome Secondary to Erlotinib: A Possible Etiology of Complications in a Patient With Pancreatic Cancer. JOP 2010, 11, 484-485.